Skip to main content
. Author manuscript; available in PMC: 2016 Sep 8.
Published in final edited form as: Am J Nephrol. 2015 Sep 8;42(2):99–106. doi: 10.1159/000439448

Table 3.

N (case/controls) MAF(case/control) Dominant model Additive model Recessive model
p-value OR (95%CI) p-value OR (95%(CI) p-value OR (95% CI)
All Subjects 1559/1332 0.30/0.22 0.31 1.09(0.92, 1.29) 0.18 1.1(0.96,1.25) 0.2 1.25(0.89,1.76)
Subjects with 0 or 1 APOL1 G1 or G2 allele 849/1139 0.21/0.19 0.38 1.09(0.90,1.32) 0.13 1.14(0.96,1.35) 0.022 1.83(1.09,3.08)
Subjects with 0 APOL1 G1 or G2 allele 374/562 0.11/0.12 0.24 0.81(0.58,1.15) 0.40 0.87(0.64,1.20) 0.41 1.6(0.52,4.90)
Subjects with 1 APOL1 G1 or G2 allele 463/574 0.28/0.26 0.38 1.12(0.87,1.45) 0.15 1.17(0.94,1.46) 0.064 1.75(0.97,3.18)
Subjects with 2 APOL1 G1 or G2 allele 722/196 0.40/0.40 0.64 1.08(0.78,1.50) 0.79 1.03(0.82,1.30) 0.92 0.98(0.64,1.50)
Subjects with 1 G1 allele 166/219 0.26/0.21 0.09 1.46(0.95,2.25) 0.084 1.41(0.96,2.08) 0.49 1.55(0.44,5.46)
Subjects with 1 G2 allele 297/355 0.30/0.28 0.75 0.95(0.70,1.31) 0.69 1.06(0.81,1.37) 0.10 1.76(0.90,3.46)
*

P-values not adjusted for multiple comparisons

OR, odds ratio